Scientists from big pharma are incorporating AI into their R&D processes to identify potential safety red flags earlier on in the development pipeline.
In this report, we showcase how AI-powered drug discovery can help reduce safety-related drug attrition.
Can we trust AI as a collaborative scientific tool?
Applications of AI in accelerating preclinical safety and toxicity assessments.
Real-world examples of how AI could help prevent late-stage failures and FDA-withdrawals.
.png "Forrester - LinkedIn Ads (LinkedIn Single Image Ad)")
